OA08242A - Imidazoquinoline antithrombogenic cardiotonic agents - Google Patents

Imidazoquinoline antithrombogenic cardiotonic agents

Info

Publication number
OA08242A
OA08242A OA58845A OA58845A OA08242A OA 08242 A OA08242 A OA 08242A OA 58845 A OA58845 A OA 58845A OA 58845 A OA58845 A OA 58845A OA 08242 A OA08242 A OA 08242A
Authority
OA
OAPI
Prior art keywords
imidazoquinoline
antithrombogenic
cardiotonic agents
cardiotonic
agents
Prior art date
Application number
OA58845A
Other languages
English (en)
Inventor
Nicholas A Meanwell
John J Wright
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA08242A publication Critical patent/OA08242A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA58845A 1985-04-25 1986-04-25 Imidazoquinoline antithrombogenic cardiotonic agents OA08242A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number Publication Date
OA08242A true OA08242A (en) 1987-10-30

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58845A OA08242A (en) 1985-04-25 1986-04-25 Imidazoquinoline antithrombogenic cardiotonic agents

Country Status (32)

Country Link
US (1) US4668686A (sh)
KR (1) KR940000828B1 (sh)
CN (1) CN1016175B (sh)
AT (1) AT390257B (sh)
AU (1) AU592983B2 (sh)
BE (1) BE904671A (sh)
CA (1) CA1298836C (sh)
CH (1) CH675722A5 (sh)
CY (1) CY1641A (sh)
DE (1) DE3614132A1 (sh)
DK (3) DK164868C (sh)
EG (1) EG18104A (sh)
ES (3) ES8708229A1 (sh)
FI (1) FI83316C (sh)
FR (1) FR2581065B1 (sh)
GB (1) GB2174987B (sh)
GR (1) GR861086B (sh)
HK (1) HK64492A (sh)
HU (1) HU195813B (sh)
IL (1) IL78581A0 (sh)
IT (1) IT1215651B (sh)
LU (1) LU86406A1 (sh)
MY (1) MY102086A (sh)
NL (1) NL8601053A (sh)
NO (1) NO163406C (sh)
NZ (1) NZ215885A (sh)
OA (1) OA08242A (sh)
PT (1) PT82460B (sh)
SE (1) SE461468B (sh)
SG (1) SG29092G (sh)
SU (3) SU1450746A3 (sh)
YU (1) YU46054B (sh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
JP2007502288A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ含有化合物
EP1658076B1 (en) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004291122A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (ja) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
HUE026571T2 (hu) 2006-08-02 2016-06-28 Cytokinetics Inc Adott kémiai anyagok, készítmények és imidazopiridineket magukba foglaló eljárások
EP2139478A4 (en) * 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
AU2012281042B2 (en) 2011-07-13 2016-07-14 Cytokinetics, Inc. Combination ALS therapy
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
IL78581A0 (en) 1986-08-31
DK190986D0 (da) 1986-04-24
MY102086A (en) 1992-03-31
NZ215885A (en) 1989-04-26
HUT42089A (en) 1987-06-29
CN1016175B (zh) 1992-04-08
SG29092G (en) 1992-05-15
CA1298836C (en) 1992-04-14
SU1470192A3 (ru) 1989-03-30
ES557551A0 (es) 1988-02-16
FI83316B (fi) 1991-03-15
ES8708229A1 (es) 1987-10-01
AU592983B2 (en) 1990-02-01
YU46054B (sh) 1992-12-21
IT1215651B (it) 1990-02-22
PT82460A (en) 1986-05-01
SE461468B (sv) 1990-02-19
EG18104A (en) 1992-09-30
IT8620206A0 (it) 1986-04-24
DE3614132A1 (de) 1986-11-27
ES8801829A1 (es) 1988-02-16
DK165249C (da) 1993-03-22
SU1560056A3 (ru) 1990-04-23
AT390257B (de) 1990-04-10
FI861684A (fi) 1986-10-26
GB2174987B (en) 1989-08-02
FR2581065B1 (fr) 1990-02-02
DK165248B (da) 1992-10-26
DK164868C (da) 1993-01-11
CH675722A5 (sh) 1990-10-31
SE8601907L (sv) 1986-10-26
NO861617L (no) 1986-10-27
PT82460B (pt) 1988-11-30
GB8610037D0 (en) 1986-05-29
HU195813B (en) 1988-07-28
ES554336A0 (es) 1987-10-01
DK190986A (da) 1986-10-26
NO163406B (no) 1990-02-12
DK165249B (da) 1992-10-26
BE904671A (fr) 1986-10-24
SU1450746A3 (ru) 1989-01-07
DK80291D0 (da) 1991-04-30
CN86102747A (zh) 1987-02-04
FI861684A0 (fi) 1986-04-22
GB2174987A (en) 1986-11-19
DK80291A (da) 1991-04-30
ES557552A0 (es) 1988-07-16
ATA112186A (de) 1989-09-15
KR940000828B1 (ko) 1994-02-02
HK64492A (en) 1992-09-04
AU5641386A (en) 1986-10-30
DK164868B (da) 1992-08-31
LU86406A1 (fr) 1986-11-05
KR860008177A (ko) 1986-11-12
GR861086B (en) 1986-09-01
SE8601907D0 (sv) 1986-04-24
FR2581065A1 (fr) 1986-10-31
ES8802521A1 (es) 1988-07-16
NO163406C (no) 1990-05-23
CY1641A (en) 1992-11-06
FI83316C (fi) 1991-06-25
NL8601053A (nl) 1986-11-17
YU116787A (en) 1988-04-30
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
DK81091D0 (da) 1991-05-01
US4668686A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
OA08242A (en) Imidazoquinoline antithrombogenic cardiotonic agents
GB8518300D0 (en) Contrast agent
GB8522535D0 (en) Contrast agent
GB8626240D0 (en) Antimicrobial agents
GB8611895D0 (en) Antistatic agents
AR243887A1 (es) Procedimiento para la preparacion de piridilcarbonil-tiazolonas cardiotonicas.
ZA863029B (en) Imidazoquinoline antithrombogenic cardiotonic agents
ZA865426B (en) Antihypertensive agents
ZA863645B (en) Yield-promoting agents
GB8513358D0 (en) Formulation
GB8525013D0 (en) Antidiarrhoel agents
GB8618196D0 (en) Antihypertensive agents
PH23175A (en) Cardiotonic aroylthiazolones
PH23182A (en) Cardiotonic alkanoylthiazolones
GR861916B (en) Antihypertensive agents
EG17810A (en) Antistatic agents
IE861087L (en) Imidazoquinoline cardiotonic agent
IE850585L (en) Benzisothiazoles-fungicidal agents
CA54825S (en) Saladware caddy
CA54285S (en) Footstool
GB8517710D0 (en) Antimicrobial agents
ZA867749B (en) Cardiotonic aroylthiazolones
IL80301A0 (en) Cardiotonic aroylthiazolones
YU119085A (en) Homogenizer
HUT40500A (en) Air-state homogenizer